Brett Sandercock - 10 Sep 2021 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Financial Officer
Signature: Brett Sandercock, Chief Financial Officer
Issuer symbol: RMD
Transactions as of: 10 Sep 2021
Transactions value $: -$1,342,250
Form type: 4
Date filed: 13 Sep 2021, 16:17
Previous filing: 23 Aug 2021
Next filing: 12 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Options Exercise	$144K	+2.5K	+2.78%	$57.76	92.3K	10 Sep 2021	Direct	F1
transaction	RMD	ResMed Common Stock	Sale	-$1.49M	-5K	-5.42%	$297.33	87.3K	10 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMD	ResMed Common Stock Options	Options Exercise	$0	-2.5K	-8.33%	$0.00	27.5K	10 Sep 2021	ResMed Common Stock	2.5K	$57.76	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was conducted under a Rule 10b5-1 plan.
F2	Represents date options first became exercisable. Options vest 1/3 per year.